TD

TD

2. ISO 3166-2 geocode for Chad. This is used as an international standard for shipping to Chad. Each region in Chad has its own code with the prefix "TD." For example, the code for the Region of Batha is ISO 3166-2:TD-BA.

Such forward-looking statements include statements about IOMAI 's ability to stimulate stronger immune responses, ease of application and tolerability of the dry patches and the estimated size of the travelers' diarrhea market.

Rifamycin SV MMX is a broad spectrum, semi-synthetic antibiotic with negligible systemic absorption, which is being developed for the treatment of patients with travelers' diarrhea and potentially for other diseases that have an infectious component in the colon.

The filing of the IND is an important milestone in the rifamycin SV MMX clinical program, and we look forward to moving forward with the development of rifamycin SV MMX for patients with travelers' diarrhea," said Gerald T.

Such forward-looking statements include statements that Iomai will successfully commercialize its travelers' diarrhea vaccine patch; that such vaccine would be approved with self-application of any dose; statements about Iomai's plans to initiate a Phase 3 study in the summer of 2009 and the potential size of the market for a travelers' diarrhea vaccine; and that, if approved, Iomai's vaccine would be the first available in the U.

Such forward-looking statements include statements about the ability of Iomai's patch vaccine to prevent travelers' diarrhea; expected government funding; sufficiency of existing cash and government contract revenues to fund operations into the second half of 2008; timing and expectation for initiating new clinical trials and completing and reporting results on Iomai's clinical trials, including follow-on Phase 2 and Phase 3 studies on the travelers' diarrhea product candidate, and Phase 1/2 study for pandemic flu dose-sparing adjuvant.

18 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that travelers who received the company's patch-based travelers' diarrhea vaccine were significantly less likely to be sickened as compared with travelers who receive a placebo, according to research presented today by Chief Scientific Officer Gregory Glenn, M.

23 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that the abstract detailing efficacy and safety results from its double-blind Phase 2 field study of a patch-based vaccine for travelers' diarrhea has been accepted as a "late breaker" presentation at Interscience Conference on Antimicrobials and Chemotherapy (ICAAC), to be held in Chicago Sept.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.